NG
NGM Biopharm
NGM·NASDAQS San Francisco CAFounded 2008200 employees
Small CapbiotechPublicMetabolicHepatology
Platform: Aldo/FGF19
Market Cap
$0.5B
All Drugs
2
Clinical Trials
4
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (NGM)
Loading NGM stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Gelirapivir | NGM-781 | NDA/BLA | 1 | JAK2 | HCC | ||
| NGM-3123 | NGM-3123 | Phase 3 | 3 | FcRn | IgANOCD |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)